EudraCT Number: 2005-001548-21 Sponsor Protocol Number: ICLA-08-CSI1 Start Date: 2005-06-21
Sponsor Name: Arpida AG
Full Title: Phase 3, Randomized, Investigator-Blind, Multi-Center Study to Evaluate Efficacy and Safety of Intravenous Iclaprim versus Intravenous Linezolid in Complicated Skin and Skin Structure Infections
Medical condition: Complicated skin and skin structure infections are predominantly caused by the following Gram-positive pathogens: Staphylococcus aureus, including methicillin-resistant strains, beta hemolytic stre...
Disease: Version SOC Term Classification Code Term Level
7.0 10040786 HLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: LV (Completed)
Trial results: (No results available)
EudraCT Number: 2004-001258-94 Sponsor Protocol Number: A2171018 Start Date: 2005-12-23
Sponsor Name: Pfizer Pharma GmbH
Full Title: One Year, Open-Label Outpatient, Parallel Group Trial Assessing the Impact of the Availability of Inhaled Insulin (Exubera®) on Glycemic Control in Patients with Type 2 Diabetes Mellitus Who Are Po...
Medical condition: Type 2 diabetes mellitus
Disease: Version SOC Term Classification Code Term Level
7 10012601 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) GB (Completed) ES (Ongoing) IT (Completed)
Trial results: View results
EudraCT Number: 2006-004650-24 Sponsor Protocol Number: IKP-219 Start Date: 2007-03-02
Sponsor Name: IKP
Full Title: Omeprazole and reflux disease - improvement of clinical outcome by genotype-adjusted dosing
Medical condition: gastrooesophageal reflux disease (GERD)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2006-004666-14 Sponsor Protocol Number: CACZ885A2206 Start Date: 2007-06-04
Sponsor Name: Novartis Pharma Services AG
Full Title: An exploratory, open label pharmacokinetic – pharmacodynamic study to compare subcutaneous versus intravenous administration of ACZ885 in adult patients with established rheumatoid arthritis.
Medical condition: Rheumatoid Arthritis
Disease: Version SOC Term Classification Code Term Level
8.1 10039073 Rheumatoid arthritis LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: BE (Completed) DE (Prematurely Ended)
Trial results: View results
EudraCT Number: 2006-001210-33 Sponsor Protocol Number: UHL 10054 Start Date: 2006-06-20
Sponsor Name: University Hospitals of Leicester NHS Trust
Full Title: A cohort study of anticholinergic drugs in South Asian women with detrusor overactivity
Medical condition: The medical condidtion is overactive bladder . A wide range of different anticholinergic agents is available to treat overactive bladder (OAB) symptoms. Within the last 15 years, ethno-pharmacologi...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Female
Trial protocol: GB (Prematurely Ended)
Trial results: View results
EudraCT Number: 2006-004545-42 Sponsor Protocol Number: TRO19622 CLEQ 1104-1 Start Date:
Sponsor Name: TROPHOS
Full Title: A double-blind, randomized, multi-center study with 500 mg QD of TRO19622 versus placebo in patients with painful peripheral diabetic neuropathy
Medical condition: Painful peripheral diabetic neuropathy
Disease: Version SOC Term Classification Code Term Level
8.1 10012680 Diabetic neuropathy LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) LV (Completed)
Trial results: (No results available)
EudraCT Number: 2006-004553-17 Sponsor Protocol Number: CC-4047-MMM-001 Start Date: 2007-04-24
Sponsor Name: Celgene Corporation
Full Title: A PHASE 2, PROSPECTIVE, RANDOMIZED, MULTICENTER, DOUBLE-BLIND, ACTIVE- CONTROL, PARALLEL-GROUP STUDY TO DETERMINE THE SAFETY OF AND TO SELECT A TREATMENT REGIMEN OF CC-4047 EITHER AS SINGLE-AGENT O...
Medical condition: Myelofibrosis with myeloid metaplasia
Disease: Version SOC Term Classification Code Term Level
9.1 10028538 Myelofibrosis with myelometaplasia LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Prematurely Ended) ES (Ongoing) AT (Completed) IT (Completed) DE (Completed)
Trial results: View results
EudraCT Number: 2006-004572-13 Sponsor Protocol Number: ARD-0301-010 Start Date: 2006-11-06
Sponsor Name: Ardana Bioscience Ltd
Full Title: A Phase II multi-centre, randomized, open-label study investigating the pharmacokinetics, pharmacodynamics, efficacy and safety of two loading dose regimens of a new GnRH antagonist, Teverelix, lon...
Medical condition: Locally advanced and/or metatstatic prostate cancer
Disease: Version SOC Term Classification Code Term Level
8.1 10060862 Prostate cancer LLT
Population Age: Adults, Elderly Gender: Male
Trial protocol: LT (Completed) LV (Completed)
Trial results: (No results available)
EudraCT Number: 2006-005462-40 Sponsor Protocol Number: 0603603 Start Date: 2007-03-26
Sponsor Name: CHU Toulouse
Full Title: Association du Velcade au Melphalan dans le conditionnement à l'autogreffe de celulles souches hématopoïétiques des patients de moins de 65 ans atteints de myélome. Etude pilote de l'Intergroupe Fr...
Medical condition: myeloma
Disease: Version SOC Term Classification Code Term Level
8.1 10028566 Myeloma LLT
Population Age: Adults Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)
EudraCT Number: 2005-004955-36 Sponsor Protocol Number: CHR-2797-002 Start Date: 2006-03-27
Sponsor Name: Chroma Therapeutics Ltd.
Full Title: A Phase I-II Study to Evaluate the Safety, Tolerability and Anti-Disease Activity of the Aminopeptidase Inhibitor, CHR-2797, in Elderly and/or Treatment Refractory Patients with Acute Myeloid Leuka...
Medical condition: Treatment refractory Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS) or Multiple Myeloma (MM)
Disease: Version SOC Term Classification Code Term Level
9.1 10000880 Acute myeloid leukaemia LLT
9.1 10028535 Myelodysplastic syndrome unclassifiable LLT
9.1 10028228 Multiple myeloma LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed) DE (Completed) BE (Completed)
Trial results: (No results available)
Medical Conditions
Sponsors and Collaborators
Drug Interventions